Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Olson

Showing results (71-80 of 122) with videos related to

Pageof 13
Sort By:
Current Neuropharmacology|August 4, 2025
Analyses of Nogo-Family Genes in Mouse and Human Microglia Omics Datasets Identify LINGO1 as a Candidate Drug Target in Alzheimer’s DiseaseElliot J. Glotfelty, Tobias E. Karlsson, Luis B. Tovar-y-Romo, et al.
The European Journal of Neuroscience|September 5, 2007
Recovery from spinal cord injury differs between rat strains in a major histocompatibility complex-independent mannerM Birdsall Abrams, Anna Josephson, Cecilia Dominguez, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 9, 2008
Cerebellar alpha-synuclein levels are decreased in Parkinson's disease and do not correlate with SNCA polymorphisms associated with disease in a Swedish materialMarie Westerlund, Andrea Carmine Belin, Anna Anvret, et al.
The European Journal of Neuroscience|February 15, 2012
Ultrastructural characterization of the mesostriatal dopamine innervation in mice, including two mouse lines of conditional VGLUT2 knockout in dopamine neuronsNoémie Bérubé-Carrière, Ginette Guay, Guillaume M Fortin, et al.
Experimental Cell Research|August 14, 2003
Nurr1 regulates dopamine synthesis and storage in MN9D dopamine cellsElisabet Hermanson, Bertrand Joseph, Diogo Castro, et al.
International Journal of Molecular Sciences|December 15, 2019
Delayed Dopamine Dysfunction and Motor Deficits in Female Parkinson Model MiceYuan-Hao Chen, Vicki Wang, Eagle Yi-Kung Huang, et al.
Neurobiology of Aging|April 19, 2008
PITX3 polymorphism is associated with early onset Parkinson's diseaseOlle Bergman, Anna Håkansson, Lars Westberg, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|December 16, 2006
Cyclooxygenase-2 polymorphisms in Parkinson's diseaseAnna Håkansson, Olle Bergman, Cecilia Chrapkowska, et al.
Neurobiology of Disease|September 23, 2006
Carbamazepine protects against megencephaly and abnormal expression of BDNF and Nogo signaling components in the mceph/mceph mouseCatharina Lavebratt, Alexandra Trifunovski, Ann-Sophie Persson, et al.
Brain Research|June 19, 2015
L-Dopa induced dyskinesias in Parkinsonian mice: Disease severity or L-Dopa historyLufei Shan, Oscar Diaz, Yajun Zhang, et al.
Pageof 13

Showing results (71-80 of 122) with videos related to

Sort By:
Pageof 13
Current Neuropharmacology|August 4, 2025
Analyses of Nogo-Family Genes in Mouse and Human Microglia Omics Datasets Identify LINGO1 as a Candidate Drug Target in Alzheimer’s DiseaseElliot J. Glotfelty, Tobias E. Karlsson, Luis B. Tovar-y-Romo, et al.
The European Journal of Neuroscience|September 5, 2007
Recovery from spinal cord injury differs between rat strains in a major histocompatibility complex-independent mannerM Birdsall Abrams, Anna Josephson, Cecilia Dominguez, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 9, 2008
Cerebellar alpha-synuclein levels are decreased in Parkinson's disease and do not correlate with SNCA polymorphisms associated with disease in a Swedish materialMarie Westerlund, Andrea Carmine Belin, Anna Anvret, et al.
The European Journal of Neuroscience|February 15, 2012
Ultrastructural characterization of the mesostriatal dopamine innervation in mice, including two mouse lines of conditional VGLUT2 knockout in dopamine neuronsNoémie Bérubé-Carrière, Ginette Guay, Guillaume M Fortin, et al.
Experimental Cell Research|August 14, 2003
Nurr1 regulates dopamine synthesis and storage in MN9D dopamine cellsElisabet Hermanson, Bertrand Joseph, Diogo Castro, et al.
International Journal of Molecular Sciences|December 15, 2019
Delayed Dopamine Dysfunction and Motor Deficits in Female Parkinson Model MiceYuan-Hao Chen, Vicki Wang, Eagle Yi-Kung Huang, et al.
Neurobiology of Aging|April 19, 2008
PITX3 polymorphism is associated with early onset Parkinson's diseaseOlle Bergman, Anna Håkansson, Lars Westberg, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|December 16, 2006
Cyclooxygenase-2 polymorphisms in Parkinson's diseaseAnna Håkansson, Olle Bergman, Cecilia Chrapkowska, et al.
Neurobiology of Disease|September 23, 2006
Carbamazepine protects against megencephaly and abnormal expression of BDNF and Nogo signaling components in the mceph/mceph mouseCatharina Lavebratt, Alexandra Trifunovski, Ann-Sophie Persson, et al.
Brain Research|June 19, 2015
L-Dopa induced dyskinesias in Parkinsonian mice: Disease severity or L-Dopa historyLufei Shan, Oscar Diaz, Yajun Zhang, et al.
Pageof 13